TR201909836T4 - Sitisinin katı farmasötik bileşimi ve bunun hazırlanması için proses. - Google Patents
Sitisinin katı farmasötik bileşimi ve bunun hazırlanması için proses. Download PDFInfo
- Publication number
- TR201909836T4 TR201909836T4 TR2019/09836T TR201909836T TR201909836T4 TR 201909836 T4 TR201909836 T4 TR 201909836T4 TR 2019/09836 T TR2019/09836 T TR 2019/09836T TR 201909836 T TR201909836 T TR 201909836T TR 201909836 T4 TR201909836 T4 TR 201909836T4
- Authority
- TR
- Turkey
- Prior art keywords
- pharmaceutical composition
- solid pharmaceutical
- citrine
- preparation
- cyticin
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000007787 solid Substances 0.000 title abstract 2
- 108091005960 Citrine Proteins 0.000 title 1
- 239000011035 citrine Substances 0.000 title 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
- 229930195725 Mannitol Natural products 0.000 abstract 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 abstract 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 abstract 1
- 229940075614 colloidal silicon dioxide Drugs 0.000 abstract 1
- 235000019700 dicalcium phosphate Nutrition 0.000 abstract 1
- 239000000314 lubricant Substances 0.000 abstract 1
- 239000000594 mannitol Substances 0.000 abstract 1
- 235000010355 mannitol Nutrition 0.000 abstract 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 abstract 1
- 239000008108 microcrystalline cellulose Substances 0.000 abstract 1
- 229940016286 microcrystalline cellulose Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Buluş, etken bir madde olarak sitisin içeren katı bir farmasötik bileşim ile ilgilidir. Bileşim, ağırlıkça %20 ila %75 arasında mikrokristalin selüloz, kayganlaştırıcı ve mannitol, koloidal silikon dioksit, kalsiyum hidrojen fosfat içeren bir gruptan seçilen farmasötik olarak kabul edilebilir en az bir yardımcı madde içermesi ile karakterize edilir, burada sitisin partiküllerinin en az %60'ı 10 pm ila 200 pm arasında boyuta sahiptir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL408608A PL408608A1 (pl) | 2014-06-18 | 2014-06-18 | Trwała stała kompozycja farmaceutyczna cytyzyny oraz sposób jej wytwarzania |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201909836T4 true TR201909836T4 (tr) | 2019-07-22 |
Family
ID=54011933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2019/09836T TR201909836T4 (tr) | 2014-06-18 | 2015-06-17 | Sitisinin katı farmasötik bileşimi ve bunun hazırlanması için proses. |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP2957280B1 (tr) |
CY (1) | CY1121986T1 (tr) |
DK (1) | DK2957280T3 (tr) |
ES (1) | ES2732711T3 (tr) |
HR (1) | HRP20191217T1 (tr) |
HU (1) | HUE044804T2 (tr) |
LT (1) | LT2957280T (tr) |
PL (2) | PL408608A1 (tr) |
PT (1) | PT2957280T (tr) |
RS (1) | RS58983B1 (tr) |
SI (1) | SI2957280T1 (tr) |
TR (1) | TR201909836T4 (tr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201602145D0 (en) * | 2016-02-05 | 2016-03-23 | Achieve Pharma Uk Ltd | Salt |
EP3598968A1 (en) | 2018-07-23 | 2020-01-29 | Adamed Pharma S.A. | Solid pharmaceutical cytisine composition |
BG67408B1 (bg) * | 2019-04-12 | 2022-01-17 | Софарма Ад | Перорален лекарствен състав с растителен алкалоид, за лечение на зависимости |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59500217A (ja) | 1982-02-22 | 1984-02-16 | ベロルススキ− ナウチノ− イスレドワ−チエルスキ− サニタルノ− ギギエニチエスキ− インスチツ−ト | 抗ニコチン効果を有する製剤およびその製造法 |
WO1997044343A1 (en) | 1996-05-20 | 1997-11-27 | Andrej Zinovyevich Vitik | Phosphorus containing cythesine derivatives |
BG65536B1 (bg) | 2004-04-16 | 2008-11-28 | "Софарма" Ад | Лекарствена форма, съдържаща цитизин |
EP2233134A1 (en) * | 2009-03-27 | 2010-09-29 | McNeil AB | Multi-portion intra-oral dosage form with organoleptic properties |
PL220354B1 (pl) | 2012-11-19 | 2015-10-30 | Aflofarm Fabryka Leków Spółka Z Ograniczoną Odpowiedzialnością | Stała postać dawkowania zawierająca zmikronizowaną cytyzynę oraz sposób jej otrzymywania |
-
2014
- 2014-06-18 PL PL408608A patent/PL408608A1/pl unknown
-
2015
- 2015-06-17 TR TR2019/09836T patent/TR201909836T4/tr unknown
- 2015-06-17 PT PT15001790T patent/PT2957280T/pt unknown
- 2015-06-17 DK DK15001790.3T patent/DK2957280T3/da active
- 2015-06-17 SI SI201530809T patent/SI2957280T1/sl unknown
- 2015-06-17 LT LTEP15001790.3T patent/LT2957280T/lt unknown
- 2015-06-17 RS RS20190766A patent/RS58983B1/sr unknown
- 2015-06-17 HU HUE15001790 patent/HUE044804T2/hu unknown
- 2015-06-17 EP EP15001790.3A patent/EP2957280B1/en active Active
- 2015-06-17 PL PL15001790T patent/PL2957280T3/pl unknown
- 2015-06-17 ES ES15001790T patent/ES2732711T3/es active Active
-
2019
- 2019-07-04 HR HRP20191217TT patent/HRP20191217T1/hr unknown
- 2019-07-10 CY CY20191100733T patent/CY1121986T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
PT2957280T (pt) | 2019-07-23 |
PL408608A1 (pl) | 2015-12-21 |
DK2957280T3 (da) | 2019-07-22 |
LT2957280T (lt) | 2019-07-25 |
ES2732711T3 (es) | 2019-11-25 |
HUE044804T2 (hu) | 2019-11-28 |
EP2957280B1 (en) | 2019-04-17 |
SI2957280T1 (sl) | 2019-08-30 |
HRP20191217T1 (hr) | 2019-10-18 |
EP2957280A1 (en) | 2015-12-23 |
PL2957280T3 (pl) | 2019-09-30 |
RS58983B1 (sr) | 2019-08-30 |
CY1121986T1 (el) | 2020-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY196319A (en) | Polycyclic TLR7/8 Antagonists and use Thereof in the Treatment of Immune Disorders | |
MX2019001096A (es) | Antagonistas del receptor 7/8 tipo toll (tlr7/8) y uso de los mismos. | |
PH12016501122A1 (en) | Delayed release compositions of linaclotide | |
SG10201810985XA (en) | Tofacitinib oral sustained release dosage forms | |
EA201690287A1 (ru) | 1,4-дизамещенные аналоги пиридазин хинолина и способы лечения состояний, связанных с smn-дефицитом | |
TW201613880A (en) | Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole | |
EA201690962A1 (ru) | Составы | |
MX348823B (es) | Formulaciones estables de linaclotida. | |
MD3310346T2 (ro) | Comprimată orodispersabilă ce conține estetrol | |
PH12016502103A1 (en) | Novel disubstituted 1,2, 4-triazine compound | |
MX2016001422A (es) | Composicion farmaceutica de fingolimod. | |
EA201791009A1 (ru) | Композиции, содержащие циклоспорин | |
MX2020002123A (es) | Sales de ribociclib y formas en estado sólido de las mismas. | |
MD4563C1 (ro) | Produs de comicronizare cu conţinut de acetat de ulipristal | |
PH12016502544A1 (en) | Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor | |
TR201909836T4 (tr) | Sitisinin katı farmasötik bileşimi ve bunun hazırlanması için proses. | |
MX366829B (es) | Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas. | |
TW201129386A (en) | Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients | |
EA201892842A1 (ru) | Фармацевтические композиции, включающие сафинамид | |
PH12019500024A1 (en) | Pharmaceutical compositions | |
MX2015015681A (es) | Composicion farmaceutica que comprende fingolimod. | |
WO2016197042A8 (en) | Modified or targeted release formulations of linaclotide | |
IN2013MU03428A (tr) | ||
WO2014122671A3 (en) | Solid oral compositions of saxagliptin | |
TN2016000561A1 (en) | Stabilized desmopressin |